阿尔茨海默病患者血清中抗淀粉样蛋白抗体的免疫耐受

目的:研究阿尔茨海默病(AD)血清中抗Aβ抗体与淀粉样蛋白结合的特性。方法:以AD患者和健康老人的血清作一抗,①用组织淀粉样斑块免疫反应(TAPIR)观察与Tg2576鼠脑内老年斑结合能力;②Western blot检测与Aβ42-GST融合蛋白的结合能力;③将Aβ42与PC12细胞培养,加入健康老人和AD患者的血清后,MTT法观察PC12细胞存活率。结果:AD患者的血清中抗Aβ抗体与成熟老年斑和Aβ42-GST融合蛋白的结合能力较弱;加入AD血清后,PC12细胞的A值较健康老人血清相比下降明显(P<0.01)。结论:AD血清中抗Aβ抗体对淀粉样蛋白可能存在着免疫耐受。

Immunologic tolerance of anti-Aβ antibody in the sera of AD patients

AIM: To characterize anti-amyloid-beta antibodies in the sera of Alzheimer's disease(AD) patients. METHODS: A special tissue amyloid plaque immunoreactivity (TAPIR) examinations of brains of Tg2576 mice was carried out. Abeta(42)-GST fusion protein was detected by Western blot. and then the survival rate of PC12 cells incubated with the sera and Abeta(42) was measured by MTT assay. RESULTS: The sera in AD patients could not recognize the senile plaque in the brains of Tg2576 mice and could not cross-react with Abeta(42)-GST fusion protein. Furthermore, PC12 cells incubated with the sera from AD patients presented the decreased A value compared with the healthy elderly(P<0.01). CONCLUSION: The anti-Abeta antibodies in the sera of AD patients may have immunologic tolerance to amyloid peptide.